The National Cancer Institute approved the following clinical research studies last month.
Lynparza (olaparib) has been approved in the European Union for the first-line maintenance treatment with bevacizumab of patients with homologous recombination deficient-positive advanced ovarian cancer.
Japan's Ministry of Health, Labor and Welfare has issued marketing authorization for Foundation for Biomedical Research and Innovation at Kobe to manufacture and supply commercial Kymriah (tisagenlecleucel) for patients in Japan.
Merck and VelosBio Inc. have entered into a definitive agreement, where Merck, through a subsidiary, will acquire all outstanding shares of VelosBio for $2.75 billion in cash.
Cancer patients and their medical teams found it beneficial when patients shared their symptoms in real time using a web- or telephone-based reporting system, according to a national multi-institutional study, the PRO-TECT trial.
Researchers found that colon cancer patients achieve better five-year survival rates when the surgeons who treat them are rated as highly skilled.
Researchers found that active surveillance is safe for African Americans with low-risk prostate cancer.
Researchers found that pancreatic cancer cells avert starvation by signaling to nerves, which grow deeply into dense tumors and secrete nutrients.
Through large-scale profiling of protein changes in response to drug treatments in cancer cell lines, researchers at MD Anderson Cancer Center have generated a resource to aid in predicting drug sensitivity, to understand therapeutic resistance mechanisms and to identify optimal combination treatment strategies.
In the election this week, voters said Yes to measures to legalize recreational cannabis (marijuana) in Arizona (60%), New Jersey (67%), and Montana (57%). Measures to legalize medical cannabis passed in Mississippi (68%) and South Dakota (54%). Patients with advanced cancer battle debilitating symptoms of pain, nausea, and anxiety, among others. Many patients have grown fearful of taking opioids despite experiencing severe cancer-related pain, because of the ongoing opioid epidemic.
